摘要:
There is described an adjustable dose injection pistol comprising a body assembly (1) including an elongate chamber (8), a piston chamber (3) including a piston (13) slideable in the chamber (8) between filled and discharged positions and means for adjusting (16, 26, 19, 20, 22, 23) one of said positions.The means comprise a selectable plurality of channels (20, 22, 23) included in one of the assemblies (1, 3), the channels (20, 22, 23) being spaced about and parallel to the piston-chamber axis, and an arrestor (19) located on the other assembly (1, 3), the arrestor (19) being selectably engageable with an aligned channel (20, 22, 23) upon movement of said piston (13) between said positions.The channels (20, 22, 23) are preferably located in the piston assembly (3) on a sleeve (16) concentrically mounted with the piston (13) and rotable with respect to the chamber (8).The pistol may be used for the injection of liquids into animals.
摘要:
A new form of nerve growth factor having a molecular weight of about 116,000 and which is stable in dilute aqueous solutions is obtained from mouse submandibular gland or mouse saliva. An extract of mouse submandibular gland or mouse saliva is subjected to ion-exchange chromatography to recover a component of the gland or saliva rich in the nerve growth factor and containing proteinaceous material which does not degrade the nerve growth factor. The pure nerve growth factor is obtained by subjecting the component rich in nerve growth factor to at least one additional chromatography step, usually two to four, to recover pure nerve growth factor having a molecular weight of about 116,000.
摘要:
Substrates such as haptens and antigens, and those for receptor proteins and native circulating binding proteins are assayed by determining bacteriolysis products occasioned by bacteriophage infection of host cells, in a modification of the "chemically modified bacteriophage assay." Thus, a substrate such as an antigen is conjugated with bacteriophage and the conjugate competes with antigen in the specimen under assay for a limited number of binding sites on antibody. Phage conjugate surviving antibody inactivation is quantified by determining intracellular constituents of host bacteria subsequently infected by the bacteriophage remaining viable, which latter can be related to the levels of antigen originally present in the specimen. A preferred embodiment involves colorimetric assay for beta galactosidase freed by phage lysis of E. coli. Generally, the method is of sensitivity comparable to that of radioimmunoassay, but is attended by substantial advantages not common to the latter technique. The method is far less cumbersome than the plaque-containing techniques hitherto employed in bacteriophage assays.
摘要:
The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic and aged subjects.
摘要:
The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3 and/or HoxB3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic subjects.
摘要:
The invention is a safety mechanism for an air-powered tool. The mechanism senses the position of the tool's implement retainer and disables the air flow to the tool's motor if the retainer is not in its locked position. The mechanism employs a pushrod that has one end adapted to contact a rear surface of the retainer when the retainer is in its lock position. The other end of the pushrod is adapted to contact a spring-biased ball-type check valve located within the air inlet to the tool's motor. When the retainer is removed from the tool, the pushrod moves forwardly under the urging of the valve and at the same time allows the valve to move to its closed position to thereby prevent any flow of pressurized air to the motor.
摘要:
A biological method for the conversion of L-glutamate to 1,4-butanediol that involves a decarboxylation step and avoids production of 4-hydroxybutyrate as an intermediate is described. The method includes: (a) conversion of L-glutamate to L-glutamate 5-phosphate; (b) conversion of L-glutamate 5-phosphate to L-glutamate 5-semialdehyde; (c) conversion of L-glutamate 5-semialdehyde to 5-hydroxy-L-norvaline; (d) conversion of 5-hydroxy-L-norvaline to 5-hydroxy-2-oxopentanoate; (e) conversion of 5-hydroxy-2-oxopentanoate to 4-hydroxybutanal; and (f) the conversion of 4-hydroxybutanal to 1,4-butanediol.
摘要:
A retainer for a pneumatic tool and assembly therefor is disclosed. The retainer includes a tool body having an internal surface defining a bore and an external surface having a threaded portion. A retainer cap is used with the tool body and includes an internal surface having a threaded portion adapted to engage the threaded portion of the tool body. An insert having an outer surface is rotatably mounted in the retainer cap. The insert includes an inner surface with a first inner surface portion adapted for conforming with a non-circular lug surface of a tool shank and a second inner surface portion radially offset from the first portion adapted for conforming with the non-circular lug surface.
摘要:
The present invention provides methods and compositions useful in localized transfer of genetic material or proteins. Moreover, the present invention provides methods and compositions for improving and/or controlling wound healing by applying a wound care device comprising HoxD3 and/or HoxA3. In addition, the present invention provides methods and compositions for improved wound healing in subjects having impaired healing capabilities, such as diabetic subjects.